Skip to main content

Adicet Bio to Participate in Upcoming Investor Conferences

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that company management will participate in three upcoming investor conferences in November.

Details of the events are as follows:

Truist Securities BioPharma Symposium, November 7, 2024, New York, NY

  • Members of management will be available for 1x1 meetings on November 7, 2024

Guggenheim Securities Healthcare Innovation Conference, November 11-13, 2024, Boston, MA

  • Chen Schor, President and Chief Executive Officer, will participate in a fireside chat on November 12, 2024 at 3:00 p.m. ET

Jefferies London Healthcare Conference, November 19-21, 2024, London

  • Chen Schor, President and Chief Executive Officer, will participate in a fireside chat on November 19, 2024 at 12:30 p.m. BST

The live audio webcasts of the fireside chats can be accessed on the Investors section of Adicet Bio’s website at http://www.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.16
+2.21 (1.01%)
AAPL  259.46
+1.01 (0.39%)
AMD  233.50
+3.27 (1.42%)
BAC  51.53
+0.43 (0.84%)
GOOG  255.00
+2.47 (0.98%)
META  740.49
+7.08 (0.97%)
MSFT  522.49
+1.95 (0.37%)
NVDA  181.93
+1.65 (0.92%)
ORCL  279.67
+7.01 (2.57%)
TSLA  423.18
-15.79 (-3.60%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.